Merck Collaborates with Maharashtra University- CME tour in ten medical colleges in Nagpur, Yavatmal, Akola, Latur, Nanded, Aurangabab, Pune, Mirag and Kolhapur in February, March and April as a first stage in India

Merck, a leading company for innovative and top-quality high-tech products in healthcare, life science and performance materials, in collaboration with Maharashtra University of Health Sciences and Directorate of Medical Education & Research is introducing European Accredited Clinical Diabetes management for more than 5000 medical students in 18 medical colleges of Maharashtra University as part of Merck Capacity Advancement Program (CAP) in Asia.

 

The course is European accredited and will be incorporated in the MBBS curricula of 18 medical colleges. It is aimed to build up the future Diabetes health care capacity in Maharashtra.

Prof. Dr Arun Jamkar, Vice Chancellor of Maharashtra University of Health Sciences, MUHS- Nashik emphasized" It gives us immense pleasure to invite the stakeholders in the field of medicine and diabetes in Maharashtra In joint collaboration with DMER and Merck, this Diabetes education course aims to provide guidelines and clinical practice for prevention, diagnosis and management of diabetes and its complications for medical undergraduates of the 18 medical colleges in Maharashtra university."

 

The 5 year program was kicked off successfully in 7 sub- Saharan countries which are Kenya, Uganda, Namibia Angola, Ghana, Tanzania and Mozambique and will further expand to other Sub-Saharan and Asian countries in 2014.

Based on its long experience in diabetes management, which began in 1957 with the development of metformin, Merck seeks to raise awareness of diabetes in India by educating the public and supporting the healthcare system to prevent, diagnose and manage the condition effectively.

As part of the Merck Capacity Advancement Program- CAP, by end of 2015, more than 5,000 medical students in partnership with  African universities such as University of Nairobi, Makerere University, Namibia University and University of Ghana, in addition to Asian universities such as  Maharashtra University in India and University of Indonesia will benefit from European-accredited clinical diabetes and chronic diseases management training, which is seeking to equip them with skills to avert the diabetes and hypertension epidemic. Merck is planning to target more than 15,000 students by the end of 2018 expanding to more African, Asian, Latin American and Middle Eastern countries with special focus on non -communicable diseases such as Diabetes, Cancer, Thyroid Dysfunction and Fertility management. The program also focuses on building research capacity and improving supply chain in order to improve patient safety in Africa.

About MERCK

Merck is a leading company for innovative and top-quality high-tech products in the pharmaceutical and chemical sectors. With its four divisions Merck Serono, Consumer Health, Performance Materials and Merck Millipore, Merck generated total revenues of € 11.1 billion in 2013. Around 39,000 Merck employees work in 66 countries to improve the quality of life for patients, to further the success of our customers and to help meet global challenges. Merck is the world's oldest pharmaceutical and chemical company - since 1668, the company has stood for innovation, business success and responsible entrepreneurship. Holding an approximately 70% interest, the founding family remains the majority owner of the company to this day. Merck, Darmstadt, Germany is holding the global rights to the Merck name and brand. The only exceptions are Canada and the United States, where the company is known as EMD.

For full info click here.